Post COVID-19 Conditions: Diagnosis and Management Options
In this webinar, Dr Anita Chopra & Dr Janna Friedly from The UW Post-COVID Rehabilitation and Recovery Clinic will discuss their treatment methods, clinical findings, and the current state of the research on Post COVID-19 conditions. This is a series of peer-to-peer learning opportunities on Long COVID. This series is an equity-driven project to help address disparities in Post-COVID-19 treatment access across Washington state by sharing the knowledge of specialists with general practitioners.
Upon completion of this educational activity, participants should be able to:
- By reviewing the most common clinical presentations, patterns and their pathophysiology, participants will be able to recognize clinical presentations of post-COVID-19 conditions.
- Participants will be able to describe the diagnostic techniques most commonly utilized to diagnose post-COVID-19 conditions.
- Participants will be able to identify available treatment management options for post-COVID-19 conditions, including integrative medicine options.
- Participants will be able to identify and illustrate ongoing research and treatment management options on the horizon.
The webinar will be recorded, and continuing education is available for physicians (MDs, DOs) and Physician Assistants (PA).
This activity is designed to educate commission members, practitioners, medical regulatory staff, and the public.
Dr. Anita Chopra, MD, FACP
Dr. Anita Chopra, MD, FACP is clinical faculty and a Board certified Internal medicine physician at UW Medicine Shoreline. She is also a physician at the Post Covid clinic at UW. She is The Founder and Medical Director of Northwest Health and Wellness, an organization focused on bridging healthcare disparities and improving access for the underserved communities. Dr. Chopra chairs the Primary Care Council for The American College of Physicians (ACP) and Co-chairs the International Medical Graduate council of the ACP, in Washington. Dr. Chopra is passionate about using Integrative approaches to providing holistic, patient centered care. She believes in making her patients active partners in their care.
Dr. Janna Friedly
Janna Friedly, M.D., is a Professor of Medicine and Rehabilitation Medicine at the University of Washington (UW) and Executive Director of the UW Post-COVID Rehabilitation and Recovery Clinic. She is the vice chair for clinical affairs for the Department of Rehabilitation Medicine. Dr. Friedly has clinical expertise in treating patients with chronic pain and extensive research experience in health services and study design.
Continuing Medical Education
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the Federation of State Medical Boards, the Washington Medical Commission, and the Washington State Department of Health. The Federation of State Medical Boards is accredited by the ACCME to provide continuing medical education for physicians. The Federation of State Medical Boards designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Credit Designation Statement
The Federation of State Medical Boards designates this internet enduring activity for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Morgan Barrett, MD
Washington Medical Commission
This learning activity is not funded by any commercial entity.
As an organization accredited by the ACCME, the Federation of State Medical Boards (FSMB) requires that the content of CME activities and related materials provide balance, independence, objectivity, and scientific rigor. All faculty, planners, and others in a position to control continuing medical education content participating in an accredited continuing education activity are required to disclose all financial relationships with ineligible companies. Ineligible companies are organizations whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. Faculty (authors, presenters, speakers and planners) are encouraged to provide a balanced view of therapeutic options by utilizing either generic names or other options available when utilizing trade names to ensure impartiality.
Faculty members are asked to disclose all financial relationships they have had in the past 24 months with ineligible companies regardless of the potential relevance of each relationship to the education and of the amount. The FSMB has implemented a mechanism to identify and resolve all conflicts of interest prior to the activity. The intent of this policy is to identify potential conflicts of interest so participants can form their own judgments with full disclosure of the facts. Participants will be asked to evaluate whether the speaker’s outside interests reflect a possible bias in the planning or presentation of the activity. The speakers, course director, and planners at the Federation of State Medical Boards, have nothing to disclose
Disclosure of Unlabeled Uses
This educational activity may contain discussion of published and/or investigational uses of agents that are not approved by the U.S. Food and Drug Administration. For additional information about approved uses, including approved indications, contraindications, and warnings, please refer to the prescribing information for each product, or consult the Physicians’ Desk Reference.
Faculty and Staff Disclosures
No speaker or persons in control of content reported intent to reference unlabeled/unapproved uses of drugs or products.